Ojha Institute of Chest Diseases


The OJHA INSTITUTE OF CHEST DISEASES (OICD) is the one of the three constituent institutes of the DUHS, since the University’s inception in December 2003.It was established as a TB sanatorium in 1939 in the form of 05 cottages by the family of Mr. Deep Chand Ojha, who was a well-known physiotherapist and whose donated his property for the relief of TB patients. It was extended to 65 Huts in 1942 by the AYUVEDIC TB relief association. During 1962-67, the Main Building of the Hospital was constructed with full facilities and bed strength of 350 beds. In 1973, it was upgraded from Sanatorium to Ojha Institute of Chest Diseases, as it is referred to today.

Message by Director


Prof. Dr. Iftekhar Ahmed


Director OICD, Professor ,Dean & HOD of Medicine DUH, Dow International Medical College, 
Dow University of Health Sciences.

At Ojha Institute of Chest Diseases (OICD), we're dedicated to making a profound difference in pulmonary healthcare, not only locally but also on a global scale. As a part of Dow University of Health Sciences (DUHS), we offer top-notch care, diagnosis, treatment, and rehabilitation for pulmonary diseases—completely free of cost.


Our commitment covers all aspects of care, from consultations to complex surgeries, including lab tests, medications, ICU services, and advanced procedures. This ensures that everyone, regardless of their financial circumstances, can access high-quality treatment.


We take immense pride in training the next generation of medical professionals through fellowships, master's, and diploma programs in pulmonary medicine. Our esteemed faculty is at the forefront of cutting-edge research, pushing the boundaries of pulmonology and contributing to advancements in healthcare.


At OICD, our team is driven by a strong sense of duty and compassion, delivering healthcare services with heart and soul. Moreover, we're taking significant strides towards creating an environmentally conscious, technologically advanced healthcare environment. We've implemented Electronic Computerized Physician Order Entry (CPOE) systems and are leveraging artificial intelligence for enhanced diagnosis and treatment.


OICD is proud to work closely day and night with the World Health Organization (WHO) on the WHO End TB Strategy post-2015. Our joint efforts aim to reduce TB-related deaths by an astounding 99% by the year 2035. We are committed to contributing to this global initiative and making a lasting impact on the fight against tuberculosis.